TickerFacts.

Kiniksa Pharmaceuticals International, plc (KNSA): Operating Income

Annual figures by period end, from SEC filings.

$77.22M
Year ended 2025-12-31
$93.22M
Trailing 12 months to 2026-03-31
+99.2%
3-year compound annual growth
2017-12-31: -$65.40M2018-12-31: -$108.16M2019-12-31: -$169.96M2020-12-31: -$157.36M2021-12-31: -$156.64M2022-12-31: $9.77M2023-12-31: -$25.20M2024-12-31: -$45.62M2025-12-31: $77.22M$77.22M
2017-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$77.22Mn/m2026-02-24, From 2025-01-01
2024-12-31-$45.62Mn/m2026-02-24, From 2024-01-01
2023-12-31-$25.20Mn/m2026-02-24, From 2023-01-01
2022-12-31$9.77Mn/m2025-02-25, From 2022-01-01
2021-12-31-$156.64Mn/m2024-02-28, From 2021-01-01
2020-12-31-$157.36Mn/m2023-03-02, From 2020-01-01
2019-12-31-$169.96Mn/m2022-02-24, From 2019-01-01
2018-12-31-$108.16Mn/m2021-02-25, From 2018-01-01
2017-12-31-$65.40Mn/a2019-03-12, From 2017-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Kiniksa Pharmaceuticals International, plc (KNSA)2025-12-31$77.22Mn/m
Ultragenyx Pharmaceutical Inc. (RARE)2025-12-31-$535.00Mn/m
Supernus Pharmaceuticals, Inc. (SUPN)2025-12-31-$62.28Mn/m
Axsome Therapeutics, Inc. (AXSM)2025-12-31-$166.76Mn/m
Amphastar Pharmaceuticals, Inc. (AMPH)2025-12-31$140.40M-31.7%
Pacira BioSciences, Inc. (PCRX)2025-12-31$19.19Mn/m
Emergent BioSolutions Inc. (EBS)2025-12-31$100.10Mn/m
TG Therapeutics, Inc. (TGTX)2025-12-31$123.32M+194.1%
Opko Health, Inc. (OPK)2025-12-31-$117.41Mn/m

Compare KNSA, RARE, SUPN, AXSM side by side · Screen every company in Pharmaceutical Preparations ↗